Company / Shares Outstanding
Syndax Pharmaceuticals Inc Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
85.7M
FY2025
5-year range
47.9M / 85.7M
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
#115 of 212
Health Care
What the data says
At 85694443.00, Syndax Pharmaceuticals Inc's shares outstanding ranks #98 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 85440.00 in FY2016 to 85694443.00 in FY2025.
Based on SEC 10-K filings.
85694443.00 in FY2025 with a 5-year CAGR of +25.9%.
Increased from 68111385.00 to 85694443.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- +25.9%
- 10-Year CAGR
- -
Sector benchmark
#98 of 212 in Health CareTop 46% of 212This company 85.7M Sector average 306.7M
▼
-72.1% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 1.0% year-over-year.
- Ranks #115 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 85.7M | +1.0% |
| FY2024 | 84.8M | +24.5% |
| FY2023 | 68.1M | +23.9% |
| FY2022 | 55.0M | +14.8% |
| FY2021 | 47.9M | +76.4% |
| FY2020 | 27.1M | +9.3% |
| FY2019 | 24.8M | +1.8% |
| FY2018 | 24.4M | +33.9% |
| FY2017 | 18.2M | +21219.3% |
| FY2016 | 85.4K | +25.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026